**Talk title is forthcoming**
Melina Claussnitzer, PhD
Associate Professor, Medicine
Harvard Medical School
Center for Genomic Medicine &
Endocrine Division
Massachusetts General Hospital
Investigator Member
The Broad Institute of MIT & Harvard
NCRC Building 18, Dining Hall
Dr. Claussnitzer co-directs the Type 2 Diabetes Systems Genomic Initiative at the Broad and serves as the associate director of scientific strategy for the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease at the Broad. Her lab focuses on the conversion of disease-associated genetic variants to function (V2F) and, more specifically, on the dissection of the genetic basis of type 2 diabetes and its comorbidities into actionable therapeutics.